Causaly raised $60m in Series B to revolutionize biomedical research
Longevity Technology - 17-Jul-2023AI-powered research platform to accelerate the processes in drug discovery and development
Join the club for FREE to access the whole archive and other member benefits.
AI platform for biomedical research
Causaly is a biomedical research discovery tool designed to find and unlock key hidden evidence to make new predictions in biomedical science. The company was founded in 2018, with an aim to redefine the boundaries of human discovery by harnessing transformative AI technologies. Causaly’s unique AI platform is a powerful catalyst for the modern Life Science research organization, reshaping how data is found, analyzed and applied in critical decision-making processes in drug discovery and development.
Supporting a broad range of complex knowledge workflows, our platform accelerates the journey from bench research and laboratory insights to the launch of life-changing therapies.
Visit website: https://www.causaly.com/
Details last updated 23-Jul-2023
AI-powered research platform to accelerate the processes in drug discovery and development